Key result
Genotype-informed shared decision-making personalizes exercise recommendations for athletes with ARVC.
Why the study?
Exercise recommendations in athletes with arrhythmogenic cardiomyopathy are shifting toward an individualized, genotype-informed approach, but applying consensus guideline recommendations into real-world practice involves clinical complexities.
Case Report (n=2)
A shared decision-making and genotype-informed approach is essential for individualizing exercise recommendations and managing risk in athletes with arrhythmogenic right ventricular cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Supports individualized counseling in ARVC athletes; extends guideline application via cases but leaves open need for prospective validation.
Exercise recommendations in athletes with arrhythmogenic cardiomyopathy are shifting toward an individualized and genotype-informed approach. Specifically, athletes with arrhythmogenic right ventricular cardiomyopathy represent a subgroup in whom the risk of disease progression and sudden cardiac death with continued high-intensity endurance exercise is considered higher. Contemporary practice, guided by consensus statements, emphasizes multidisciplinary care and shared decision-making to inform sports participation advice and overall disease management. We highlight these principles and the clinical complexities faced when applying guideline recommendations into real-world practice through 2 illustrative cases.
No takes yet. Share an insight, caveat, or question.
Aljohar et al. (2026) conducted a case report in Arrhythmogenic right ventricular cardiomyopathy (ARVC) (n=2). Shared decision-making and genotype-informed exercise recommendations was evaluated. Shared decision-making and genotype-informed individualized risk assessment are essential for managing exercise recommendations in athletes with arrhythmogenic right ventricular cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: